Bristol Myers Squibb (NYSE: BMY) recently reported its Q3 results, with revenues and earnings exceeding the street estimates.

Global Markets to 2029" looks at the growing demand for inactive ingredients in medications. The market for Excipients, which enhance drug stability ...

Q3 2024 Earnings Call Transcript November 7, 2024 BlackLine, Inc. beats earnings expectations. Reported EPS is $0.6, ...

Endo, Inc. ("Endo" or the "Company") (OTCQX: NDOI), a diversified specialty pharmaceutical company transforming insights into life-enhancing therapies ...

AstraZeneca – This pharmaceutical company uses Frutiger within its corporate ... Box – This cloud storage service uses the font in its logo design and across all user interfaces (UI) to emphasise ...

Iran seems to have weaponized the pharmaceutical fentanyl. It may have given these chemical weapons to Hamas and Hezbollah to ...

Zealand Pharma A/S ( (ZLDPF) ) has released its Q3 earnings. Here is a breakdown of the information Zealand Pharma A/S presented to its ...

Cipher Pharmaceuticals (TSE:CPH) has released an update. Cipher Pharmaceuticals reported significant growth in the third quarter of 2024, with ...

Explore how dynamic vapor sorption (DVS) technology is revolutionizing pharmaceutical development by improving material ...

What is Pharma 4.0? The term Industry 4.0 refers to the fourth industrial revolution, associated with the application of advanced technologies that have dramatically changed the landscape of ...

Bill Burr is sure to generate conversation for his off-color opening monologue jokes, calling for women politicians to 'whore ...

FREIBURG, GERMANY / ACCESSWIRE / October 29, 2024 / Today, Dr. Falk Pharma GmbH announces the successful acquisition of Kynos Therapeutics Ltd., a clinical stage biopharmaceutical company focusing on ...